KMTS · NASDAQ · Medical - Instruments & Supplies

Kestra Medical Technologies (KMTS)

Leases connected wearable defibrillator systems for patients at elevated sudden-cardiac-arrest risk.

$25.75
At close+0.63 (+2.51%)

In millions of USD, except per-share figures

In millionsQ1 FY21Jul 2020Q1 FY22Jul 2021Q3 FY24Jan 2024Q4 FY24Apr 2024Q1 FY25Jul 2024Q2 FY25Oct 2024Q3 FY25Jan 2025Q4 FY25Apr 2025Q1 FY26Jul 2025Q2 FY26Oct 2025Q3 FY26Jan 2026Q4 FY26Apr 2026
Revenue008101315151719232529
Cost of revenue00799991011111213
Gross profit001146789111316
81221222325275638434855
Research & development654434354556
2717181921245034384349
Selling & marketing270000000000
Operating income−8−12−20−20−18−19−21−48−29−32−35−39
0−1−2−2−2−1−1−33−111
Interest income00000012222−2
Interest expense012221222222
Other non-operating income000000−11−5−1−30
Income before tax−8−13−22−22−20−21−22−51−26−33−34−39
Income tax expense000000000000
Net income from continuing operations−8−13−22−22−20−21−22−51−26−33−34−39
Other adjustments0000000−10000
Net income−8−13−22−22−20−20−22−52−26−33−34−39
EPS, basic−$0.16−$0.27−$0.47−$0.45−$0.45−$0.48−$0.50−$2.21−$0.50−$0.64−$0.61−$0.67
EPS, diluted−$0.16−$0.27−$0.47−$0.45−$0.45−$0.48−$0.50−$2.21−$0.50−$0.64−$0.61−$0.67
Weighted average shares, basic505050505050505051515358
Weighted average shares, diluted505050505050505051515358
EBITDA−8−12−17−17−16−17−18−47−22−28−30−50
Depreciation & amortization00342222222−11
EBIT−8−12−20−20−18−19−20−49−24−31−32−39